CMPK1 is also the target of three FDA approved cancer drugs (Gemcitabine, Lamivudine, and Sofosbuvir) for the treatment of diseases induced by a virus infection, such as HCC caused by HBV/hepatitis C virus. Here, CMPK1 is linked to hepatocellular carcinoma.